Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chang Liu, Jiangwei Li, Qianqian Hu, Xinlan Xu & Xin Zhang. (2023) Generation of a CD70-Specific Fusion Nanobody with IgG Recruiting Capacity for Tumor Killing. International Journal of Nanomedicine 18, pages 3325-3338.
Read now
Read now
Junli Ding, Hao Wang, Rui Hou, Yuxin Shi, Honghong Fan, Yuting Li, Jie Mei, Qinglin Zhang, Tingyan Ruan & Junying Xu. (2023) Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer. International Journal of General Medicine 16, pages 2285-2294.
Read now
Read now
Joshua W. Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G. Daver, Courtney D. DiNardo, Ningyan Zhang & Zhiqiang An. (2023) Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert Opinion on Investigational Drugs 32:2, pages 107-125.
Read now
Read now
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now
Read now
Articles from other publishers (46)
Fan-kai Xiao & Lin Wang. (2023) Comprehensive Analysis of Expression and Pathway for CD27 in Esophageal Cancer. Molecular Biotechnology.
Crossref
Crossref
Judith Leitner, Ricarda Egerer, Petra Waidhofer-Söllner, Katharina Grabmeier-Pfistershammer & Peter Steinberger. (2023) FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab. Frontiers in Immunology 14.
Crossref
Crossref
Xiaoxu Li, Yinlin Guo, Minmin Xiao & Wenling Zhang. (2023) The immune escape mechanism of nasopharyngeal carcinoma. The FASEB Journal 37:7.
Crossref
Crossref
Ana-Maria Ciongariu, Adrian-Vasile Dumitru, Cătălin Cîrstoiu, Bogdan Crețu, Maria Sajin, Dana-Antonia Țăpoi, Aminia-Diana Ciobănoiu, Adrian Bejenariu, Andrei Marin & Mariana Costache. (2023) The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review. Medicina 59:5, pages 967.
Crossref
Crossref
Shingo Inaguma, Akane Ueki, Jerzy Lasota, Masayuki Komura, Asraful Nahar Sheema, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat, David S Schrump, Raffit Hassan, Markku Miettinen & Satoru Takahashi. (2023)
CD70
and
PD‐L1
(
CD274
) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma
. The Journal of Pathology: Clinical Research 9:3, pages 195-207.
Crossref
Crossref
Fanhua Kong, Qifa Ye & Yan Xiong. (2023) Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer. Functional & Integrative Genomics 23:1.
Crossref
Crossref
Josefine Jakob, Andrea Kröger, Frank Klawonn, Dunja Bruder & Lothar Jänsch. (2023) Translatome analyses by bio-orthogonal non-canonical amino acid labeling reveal that MR1-activated MAIT cells induce an M1 phenotype and antiviral programming in antigen-presenting monocytes. Frontiers in Immunology 14.
Crossref
Crossref
Fang Wang, Wenhao Zhang, Ying Chai, Hanshao Wang, Zhonglong Liu & Yue He. (2022) Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Xin Zhang, Chang Liu, Yuan Xie, Qianqian Hu, Yuanyuan Chen & Jiangwei Li. (2022) Identification and characterization of blocking nanobodies against human CD70. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Lars Guelen, Thierry O Fischmann, Jerelyn Wong, Smita Mauze, Marco Guadagnoli, Nikolina Bąbała, Jozef Wagenaars, Veronica Juan, David Rosen, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Judith Stammen-Vogelzangs, Ying Yu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Yiwei Zhang, Richard Wnek, Sean Troth, Elliot Chartash, Konstantin Dobrenkov, Svetlana Sadekova, Andrea van Elsas, Jason K Cheung, Laurence Fayadat-Dilman, Jannie Borst, Amy M Beebe & Hans Van Eenennaam. (2022) Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 10:9, pages e005049.
Crossref
Crossref
Tod HarperJrJr, Amy Sharma, Sarav Kaliyaperumal, Flordeliza Fajardo, Katie Hsu, Lily Liu, Rhian Davies, Yu-Ling Wei, Jinghui Zhan, Juan Estrada, Majk Kvesic, Lisa Nahrwold, Wibke Deisting, Marc Panzer, Keegan Cooke, Hervé Lebrec & Olivier Nolan-Stevaux. (2022) Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus Monkeys. Toxicological Sciences 189:1, pages 32-50.
Crossref
Crossref
Yuhan Tu, Zhiang Yao, Wenjing Yang, Shanhui Tao, Bin Li, Yun Wang, Zhijian Su & Shijun Li. (2022) Application of Nanoparticles in Tumour Targeted Drug Delivery and Vaccine. Frontiers in Nanotechnology 4.
Crossref
Crossref
George Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, João Pedro Ferreira, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos, Chim C Lang, Marco Metra, Nilesh J Samani, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors & Peter van der Meer. (2022) Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovascular Research 118:8, pages 1964-1977.
Crossref
Crossref
Katsiaryna Marhelava, Marta Krawczyk, Malgorzata Firczuk & Klaudyna Fidyt. (2022) CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies. Cells 11:11, pages 1804.
Crossref
Crossref
Mathieu Seyfrid, William Thomas Maich, Muhammad Vaseem Shaikh, Nazanin Tatari, Deepak Upreti, Deween Piyasena, Minomi Subapanditha, Neil Savage, Dillon McKenna, Nicholas Mikolajewicz, Hong Han, Chirayu Chokshi, Laura Kuhlmann, Amanda Khoo, Sabra Khalid Salim, Blessing Archibong-Bassey, William Gwynne, Kevin Brown, Nadeem Murtaza, David Bakhshinyan, Parvez Vora, Chitra Venugopal, Jason Moffat, Thomas Kislinger & Sheila Singh. (2022) CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. Journal for ImmunoTherapy of Cancer 10:1, pages e003289.
Crossref
Crossref
Marius Maucher, Micha Srour, Sophia Danhof, Hermann Einsele, Michael Hudecek & Ibrahim Yakoub-Agha. (2021) Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia. Cancers 13:24, pages 6157.
Crossref
Crossref
Rowan AlEjielat, Anas Khaleel & Amneh H. Tarkhan. (2021) Differential gene expression analysis of ankylosing spondylitis shows deregulation of the HLA-DRB, HLA-DQB, ITM2A, and CTLA4 genes. Egyptian Journal of Medical Human Genetics 22:1.
Crossref
Crossref
Chunxu Gao, Debra Gardner, Marie-Clare Theobalds, Shannon Hitchcock, Heather Deutsch, Chidozie Amuzie, Matteo Cesaroni, Davit Sargsyan, Tadimeti S Rao & Ravi Malaviya. (2021) Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression. Clinical and Experimental Immunology 206:3, pages 422-438.
Crossref
Crossref
Weifeng Liu, Zachary Maben, Carole Wang, Kevin C. Lindquist, Manqing Li, Vinayak Rayannavar, Ilsel Lopez Armenta, Andrew Nager, Edward Pascua, Pawel K. Dominik, David Oyen, Hui Wang, Rachel Carson Roach, Corey M. Allan, Lidia Mosyak & Javier Chaparro-Riggers. (2021) Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex. Journal of Biological Chemistry 297:4, pages 101102.
Crossref
Crossref
Ciro Novaes Rosa Lino & Sujal Ghosh. (2021) Epstein–Barr Virus in Inborn Immunodeficiency—More Than Infection. Cancers 13:19, pages 4752.
Crossref
Crossref
Mayu Shiomi, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Chihiro Mizuta‐Odani, Mariko Jitsumori, Ruriko Nakae, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Yutaka Ueda, Kiyoshi Yoshino, Tetsuji Naka & Tadashi Kimura. (2021) CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer. Cancer Science 112:9, pages 3655-3668.
Crossref
Crossref
Letizia Polito, Giulia Calafato, Massimo Bortolotti, Cecilia Chiarelli Olivari, Stefania Maiello & Andrea Bolognesi. (2021) Antibody Conjugates for Sarcoma Therapy: How Far along Are We?. Biomedicines 9:8, pages 978.
Crossref
Crossref
Xi-Yang Tang, An-Ping Shi, Yan-Lu Xiong, Kai-Fu Zheng, Yu-Jian Liu, Xian-Gui Shi, Tao Jiang & Jin-Bo Zhao. (2021) Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis. Frontiers in Oncology 11.
Crossref
Crossref
Nitish Khurana, Abigail Pulsipher, Hamidreza Ghandehari & Jeremiah A. Alt. (2021) Meta-analysis of global and high throughput public gene array data for robust vascular gene expression discovery in chronic rhinosinusitis: Implications in controlled release. Journal of Controlled Release 330, pages 878-888.
Crossref
Crossref
Ruriko Nakae, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Mayu Shiomi, Kazuaki Sato, Yoshikazu Nagase, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu, Akiko Okazawa, Toshihiro Kimura, Tomomi Egawa-Takata, Eiji Kobayashi, Yutaka Ueda, Kiyoshi Yoshino, Tetsuji Naka & Tadashi Kimura. (2021) CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. American Journal of Obstetrics and Gynecology 224:2, pages 197.e1-197.e23.
Crossref
Crossref
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro & Gaël Roué. (2021) Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13:2, pages 214.
Crossref
Crossref
Qiang He, Shuyin Xue, Qingbiao Wa, Mei He, Shuang Feng, Zhibing Chen, Wei Chen & Xinrong Luo. (2021) Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma. Medicine 100:17, pages e25715.
Crossref
Crossref
Sujal GhoshSevgi Köstel Bal, Emily S. J. Edwards, Bethany PillayRaúl Jiménez HerediaFunda Erol Cipe, Geetha RaoElisabeth SalzerSamaneh Zoghi, Hassan Abolhassani, Tooba MomenEmma GostickDavid A. Price, Yu Zhang, Andrew J. Oler, Claudia Gonzaga-Jauregui, Baran Erman, Ayse Metin, Inci IlhanSule Haskologlu, Candan Islamoglu, Kubra BaskinSerdar Ceylaner, Ebru Yilmaz, Ekrem Unal, Musa Karakukcu, Dagmar BerghuisTheresa ColeAditya K. GuptaFabian Hauck, Hubert KoglerAndy I. M. Hoepelman, Safa BarisElif Karakoc-AydinerAhmet OzenLeo KagerDirk Holzinger, Michael PaulussenRenate Krüger, Roland MeiselPrasad T. Oommen, Emma Morris, Benedicte NevenAusten Worth, Joris van MontfransPieter L. A. FraaijSharon ChooFigen DoguE. Graham DaviesSiobhan BurnsGregor DückersRuy Perez BeckerHorst von BernuthSylvain Latour, Maura FaraciMarco GattornoHelen C. Su, Qiang Pan-Hammarström, Lennart HammarströmMichael J. Lenardo, Cindy S. Ma, Tim NiehuesAsghar Aghamohammadi, Nima Rezaei, Aydan Ikinciogullari, Stuart G. Tangye, Arjan C. LankesterKaan Boztug. (2020) Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood 136:23, pages 2638-2655.
Crossref
Crossref
Yingying Wang, Yu Xu, Qingquan Hua, Yang Jiang, Peiqiang Liu, Wei Zhang & Rong Xiang. (2020) Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Urs B. HagemannKatrine WickstroemStefanie HammerRoger M. BjerkeSabine Zitzmann-KolbeOlav B. RyanJenny KarlssonArne ScholzHartwig HennekesDominik MumbergAlan S. Cuthbertson. (2020) Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy. Cancer Biotherapy and Radiopharmaceuticals 35:7, pages 497-510.
Crossref
Crossref
Thi K. Tran-Nguyen, Jianmin Xue, Carol Feghali-Bostwick, Frank C. Sciurba, Daniel J. Kass & Steven R. Duncan. (2020) CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins. American Journal of Respiratory Cell and Molecular Biology 63:2, pages 255-265.
Crossref
Crossref
Shingo Inaguma, Jerzy Lasota, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat, David S Schrump, Raffit Hassan, Kenji Kasai, Markku Miettinen & Hiroshi Ikeda. (2019) CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness. The Journal of Pathology 250:2, pages 205-216.
Crossref
Crossref
Tal Flieswasser, Valérie Camara-Clayette, Alina Danu, Jacques Bosq, Vincent Ribrag, Piotr Zabrocki, Luc Van Rompaey, Hans de Haard, Karen Zwaenepoel, Evelien Smits, Patrick Pauwels & Julie Jacobs. (2019) Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method. Cancers 11:10, pages 1611.
Crossref
Crossref
Tessa Dhaeze, Laurence Tremblay, Catherine Lachance, Evelyn Peelen, Stephanie Zandee, Camille Grasmuck, Lyne Bourbonnière, Sandra Larouche, Xavier Ayrignac, Rose-Marie Rébillard, Josée Poirier, Boaz Lahav, Pierre Duquette, Marc Girard, Robert Moumdjian, Alain Bouthillier, Catherine Larochelle & Alexandre Prat. (2019) CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cellular & Molecular Immunology 16:7, pages 652-665.
Crossref
Crossref
Sebastian Chrétien, Ioannis Zerdes, Jonas Bergh, Alexios Matikas & Theodoros Foukakis. (2019) Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy. Cancers 11:5, pages 628.
Crossref
Crossref
Jumpei Kashima, Yusuke Okuma, Yukio Hosomi & Tsunekazu Hishima. (2019) High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung Cancer. Oncology 97:6, pages 365-372.
Crossref
Crossref
Angelika M. Starzer & Anna S. Berghoff. (2019) New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open 4, pages e000629.
Crossref
Crossref
Michelle H. Townsend, Gajendra Shrestha, Richard A. Robison & Kim L. O’Neill. (2018) The expansion of targetable biomarkers for CAR T cell therapy. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Meinolf Thiemann, David M. Richards, Karl Heinonen, Michael Kluge, Viola Marschall, Christian Merz, Mauricio Redondo Müller, Tim Schnyder, Julian P. Sefrin, Jaromir Sykora, Harald Fricke, Christian Gieffers & Oliver Hill. (2018) A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity. Frontiers in Oncology 8.
Crossref
Crossref
Imo E. Hoefer & Saskia C.A. de Jager. (2018) Janus revisited: The intricate role of the immune system in neovascularization. International Journal of Cardiology 260, pages 193-194.
Crossref
Crossref
Joana M. Murad, David J. Graber & Charles L. Sentman. (2018) Advances in the use of natural receptor- or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies. Best Practice & Research Clinical Haematology 31:2, pages 176-183.
Crossref
Crossref
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, Fritz Offner, Dominique Bron, Marie Maerevoet, Jean-Charles Soria, Mahan Moshir, Torsten Dreier, Luc Van Rompaey, Jean-Marie Michot, Karen Silence, Anna Hultberg, Domenica Gandini, Hans de Haard, Vincent Ribrag, Marc Peeters, Alain Thibault, Nicolas Leupin & Ahmad Awada. (2017) Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies. Clinical Cancer Research 23:21, pages 6411-6420.
Crossref
Crossref
Urs B. Hagemann, Dessislava Mihaylova, Steinar R. Uran, Joergen Borrebaek, Derek Grant, Roger M. Bjerke, Jenny Karlsson & Alan S. Cuthbertson. (2017)
Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in
in vitro
and
in vivo
models of renal cell carcinoma
. Oncotarget 8:34, pages 56311-56326.
Crossref
Crossref
Alexey Teplyakov, Galina Obmolova, Thomas J. Malia & Gary L. Gilliland. (2017) Crystal structure of CD27 in complex with a neutralizing noncompeting antibody. Acta Crystallographica Section F Structural Biology Communications 73:5, pages 294-299.
Crossref
Crossref
Jeremy D. Waight, Randi B. Gombos & Nicholas S. Wilson. (2017) Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities. Human Antibodies 25:3-4, pages 87-109.
Crossref
Crossref
Emma J Grant, Simone Nüssing, Sneha Sant, E Bridie Clemens & Katherine Kedzierska. (2017) The role of CD27 in anti-viral T-cell immunity. Current Opinion in Virology 22, pages 77-88.
Crossref
Crossref